0001140361-15-045654.txt : 20151228
0001140361-15-045654.hdr.sgml : 20151225
20151228142004
ACCESSION NUMBER: 0001140361-15-045654
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151223
FILED AS OF DATE: 20151228
DATE AS OF CHANGE: 20151228
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abdun-Nabi Daniel
CENTRAL INDEX KEY: 0001380187
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 151308933
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD, SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc1.xml
FORM 4
X0306
4
2015-12-23
0
0001367644
Emergent BioSolutions Inc.
EBS
0001380187
Abdun-Nabi Daniel
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
1
0
0
President & CEO
Common Stock
2015-12-23
4
M
0
40354
18.90
A
225722
D
Common Stock
2015-12-23
4
S
0
40354
38.99
D
185368
D
Common Stock
2015-12-24
4
M
0
22855
18.90
A
208223
D
Common Stock
2015-12-24
4
S
0
22855
39.17
D
185368
D
Stock Option
18.90
2015-12-23
4
M
0
40354
0
D
2019-03-09
Common Stock
40354
22855
D
Stock Option
18.90
2015-12-24
4
M
0
22855
0
D
2019-03-09
Common Stock
22855
0
D
Consists of an option granted under the company's stock incentive plan on March 10, 2009.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.79 to $39.11, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.99 to $39.48, inclusive.
The option vested in three equal installments in March 2010, 2011 and 2012.
/s/ Eric Burt, attorney-in-fact
2015-12-28